collection
https://read.qxmd.com/read/26680389/innovations-in-bariatric-surgery
#1
REVIEW
Catherine Zhu, Aurora D Pryor
Surgery has consistently been demonstrated to be the most effective long-term therapy for the treatment of obesity. However, despite excellent outcomes with current procedures, most patients with obesity- and weight-related comorbidities who meet criteria for surgical treatment choose not to pursue surgery out of fear of operative risks and complications or concerns about high costs. Novel minimally invasive procedures and devices may offer alternative solutions for patients who are hesitant to pursue standard surgical approaches...
November 2015: Surgical Technology International
https://read.qxmd.com/read/26765107/the-future-of-surgical-oncology-image-guided-cancer-surgery
#2
JOURNAL ARTICLE
Sunil Singhal
No abstract text is available yet for this article.
February 2016: JAMA Surgery
https://read.qxmd.com/read/26694640/bariatric-surgery-in-the-united-kingdom-a-cohort-study-of-weight-loss-and-clinical-outcomes-in-routine-clinical-care
#3
JOURNAL ARTICLE
Ian J Douglas, Krishnan Bhaskaran, Rachel L Batterham, Liam Smeeth
BACKGROUND: Bariatric surgery is becoming a more widespread treatment for obesity. Comprehensive evidence of the long-term effects of contemporary surgery on a broad range of clinical outcomes in large populations treated in routine clinical practice is lacking. The objective of this study was to measure the association between bariatric surgery, weight, body mass index, and obesity-related co-morbidities. METHODS AND FINDINGS: This was an observational retrospective cohort study using data from the United Kingdom Clinical Practice Research Datalink...
December 2015: PLoS Medicine
https://read.qxmd.com/read/20203013/metabolic-syndrome-and-altered-gut-microbiota-in-mice-lacking-toll-like-receptor-5
#4
JOURNAL ARTICLE
Matam Vijay-Kumar, Jesse D Aitken, Frederic A Carvalho, Tyler C Cullender, Simon Mwangi, Shanthi Srinivasan, Shanthi V Sitaraman, Rob Knight, Ruth E Ley, Andrew T Gewirtz
Metabolic syndrome is a group of obesity-related metabolic abnormalities that increase an individual's risk of developing type 2 diabetes and cardiovascular disease. Here, we show that mice genetically deficient in Toll-like receptor 5 (TLR5), a component of the innate immune system that is expressed in the gut mucosa and that helps defend against infection, exhibit hyperphagia and develop hallmark features of metabolic syndrome, including hyperlipidemia, hypertension, insulin resistance, and increased adiposity...
April 9, 2010: Science
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.